BORTEZOMIB WAVERLEY Pharma Europe LIMITED 1 mg, poudre pour solution injectable France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

bortezomib waverley pharma europe limited 1 mg, poudre pour solution injectable

waverley pharma europe limited - bortézomib - poudre - 1 mg - composition pour un flacon > bortézomib : 1 mg . sous forme de : ester boronique de mannitol - agents antinéoplasiques, autres agents antinéoplasiques

BORTEZOMIB WAVERLEY Pharma Europe LIMITED 3,5 mg, poudre pour solution injectable France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

bortezomib waverley pharma europe limited 3,5 mg, poudre pour solution injectable

waverley pharma europe limited - bortézomib - poudre - 3,5 mg - composition pour un flacon > bortézomib : 3,5 mg . sous forme de : ester boronique de mannitol - agents antinéoplasiques, autres agents antinéoplasiques

Imbruvica Union européenne - français - EMA (European Medicines Agency)

imbruvica

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

SYNACTHEN DEPÔT Suspension Canada - français - Health Canada

synacthen depôt suspension

atnahs pharma uk limited - tétracosactide (complexe tétracosactide-hydroxyde de zinc) - suspension - 1mg - tétracosactide (complexe tétracosactide-hydroxyde de zinc) 1mg - adrenocortical insufficiency

LUPIN-TRAMADOL/ACET Comprimé Canada - français - Health Canada

lupin-tramadol/acet comprimé

lupin pharma canada limited - chlorhydrate de tramadol; acétaminophène - comprimé - 37.50mg; 325.00mg - chlorhydrate de tramadol 37.50mg; acétaminophène 325.00mg - opiate agonists

JENCYCLA Comprimé Canada - français - Health Canada

jencycla comprimé

lupin pharma canada limited - noréthindrone - comprimé - 0.35mg - noréthindrone 0.35mg - contraceptives

DIPENTUM Capsule Canada - français - Health Canada

dipentum capsule

atnahs pharma uk limited - olsalazine sodique - capsule - 250mg - olsalazine sodique 250mg - anti-inflammatory agents

PHARMA-TELMISARTAN Comprimé Canada - français - Health Canada

pharma-telmisartan comprimé

pharmascience inc - telmisartan - comprimé - 40mg - telmisartan 40mg - angiotensin ii receptor antagonists

PHARMA-TELMISARTAN Comprimé Canada - français - Health Canada

pharma-telmisartan comprimé

pharmascience inc - telmisartan - comprimé - 80mg - telmisartan 80mg - angiotensin ii receptor antagonists

LUPIN-TIOTROPIUM Capsule Canada - français - Health Canada

lupin-tiotropium capsule

lupin pharma canada limited - tiotropium (bromure de tiotropium monohydraté) - capsule - 18mcg - tiotropium (bromure de tiotropium monohydraté) 18mcg